Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Keytruda/Keytruda Qlex Revenue	32.51B	31.68B	29.48B
Gardasil/Gardasil 9 Revenue	4.98B	5.23B	8.58B
Januvia/Janumet Revenue	2.32B	2.54B	2.27B
ProQuad/M-M-R II/Varivax Revenue	2.45B	2.45B	2.49B
Bridion Revenue	1.87B	1.84B	1.76B
Lynparza - Alliance Revenue	1.48B	1.45B	1.31B
Winrevair Revenue	1.69B	1.44B	419.00M
Lenvima - Alliance Revenue	1.05B	1.05B	1.01B
Pharmaceutical Revenue	58.85B	58.14B	57.40B
Animal Health Revenue	6.56B	6.35B	5.88B
Other Product Revenue	358.00M	515.00M	891.00M
Revenue (Other)	-48.35B	-47.70B	-47.32B
Revenue (Total)	65.77B	65.01B	64.17B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	37.15B	36.51B	32.28B
Europe, Middle East and Africa Revenue	15.02B	14.58B	14.04B
Latin America Revenue	3.49B	3.41B	3.46B
China Revenue	1.63B	1.94B	5.49B
Asia Pacific (other than China and Japan) Revenue	3.03B	2.98B	3.06B
Japan Revenue	2.60B	2.71B	3.28B
Other Geographic Revenue	2.85B	2.88B	2.56B
Revenue (Other)	-1.00M	-	-
Revenue (Total)	65.77B	65.01B	64.17B

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Pharmaceutical Segment Profit	46.56B	45.75B	44.53B
Animal Health Segment Profit	2.22B	2.13B	1.94B
Other Segment Profit	-9.13B	-26.82B	-26.54B